BWAY vs. INMD, MDXG, KMTS, SIBN, IRMD, CBLL, EMBC, BBNX, AVNS, and BVS
Should you be buying Brainsway stock or one of its competitors? The main competitors of Brainsway include InMode (INMD), MiMedx Group (MDXG), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), Embecta (EMBC), Beta Bionics (BBNX), AVANOS MEDICAL (AVNS), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.
Brainsway vs. Its Competitors
InMode (NASDAQ:INMD) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.
In the previous week, InMode had 11 more articles in the media than Brainsway. MarketBeat recorded 12 mentions for InMode and 1 mentions for Brainsway. Brainsway's average media sentiment score of 1.87 beat InMode's score of 0.65 indicating that Brainsway is being referred to more favorably in the news media.
InMode has a net margin of 44.79% compared to Brainsway's net margin of 9.01%. InMode's return on equity of 17.17% beat Brainsway's return on equity.
InMode currently has a consensus price target of $18.54, indicating a potential upside of 30.12%. Brainsway has a consensus price target of $14.25, indicating a potential upside of 16.80%. Given InMode's higher possible upside, equities analysts plainly believe InMode is more favorable than Brainsway.
InMode has a beta of 1.95, suggesting that its stock price is 95% more volatile than the S&P 500. Comparatively, Brainsway has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500.
68.0% of InMode shares are held by institutional investors. Comparatively, 30.1% of Brainsway shares are held by institutional investors. 6.9% of InMode shares are held by insiders. Comparatively, 19.0% of Brainsway shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
InMode has higher revenue and earnings than Brainsway. InMode is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.
Summary
InMode beats Brainsway on 10 of the 16 factors compared between the two stocks.
Get Brainsway News Delivered to You Automatically
Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Brainsway Competitors List
Related Companies and Tools
This page (NASDAQ:BWAY) was last updated on 7/15/2025 by MarketBeat.com Staff
Free BWAY Stock Alerts